drugset / Trial / NCT06548997
A Phase I Study of GZR18 Injection in Healthy Subjects
RandomizedSequentialDouble-blindTreatment
Summary
This trial is conducted in China. The aim of the trial is to evaluate the safety and tolerability of GZR18 injection in healthy subjects following single dose and once-weekly dose for 2 consecutive weeks until reaching the target dose.
Timeline
- Start
- 2021-12-02
- Primary completion
- 2022-10-20
- Completion
- 2022-10-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bofanglutide | Protein / enzyme biologic | 5 ug/kg | — |